Diabetes Drugs and Diagnostics Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2021-26

1
Global Diabetes Drugs and Diagnostics Market
Research and Forecast Report 2021-2026




Author Elena Anderson, Marketing Manager
IMARC Group
Copyright IMARC Service Pvt Ltd. All Rights
Reserved
2019 IMARC All Rights Reserved
2
About IMARC Group
Report Description
The International Market Analysis Research and
Consulting Group is a leading adviser on
management strategy and market research
worldwide. We partner with clients in all sectors
and regions to identify their highest-value
opportunities, address their most critical
challenges, and transform their
businesses. IMARCs information products include
major market, scientific, economic and
technological developments for business leaders
in pharmaceutical, industrial, and high
technology organizations. Market forecasts and
industry analysis for biotechnology, advanced
materials, chemicals, food and beverage, travel
and tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Global Diabetes Drugs and Diagnostics Market
Research Report According to the latest report
by IMARC Group, titled "Diabetes Drugs and
Diagnostics Market Global Industry Trends,
Share, Size, Growth, Opportunity and Forecast
2021-2026," the global diabetes drugs and
diagnostics market reached a strong growth in
2020. Diabetes is a metabolic disease that
occurs as a result of elevated blood glucose
levels in an individual. This is usually caused
when the pancreas does not produce adequate
insulin, a hormone that regulates blood sugar, or
due to the bodys inefficiency in utilizing the
produced hormone. It is a chronic disease that
can cause severe damage to the blood vessels
present in the eyes, heart and kidneys if left
undiagnosed and untreated. As a result,
efficient diagnostic services are widely
available to determine blood glucose levels in a
convenient and quick manner. Numerous
antidiabetic medicines, including oral and
injectable drugs, are also prescribed by various
healthcare professionals for the effective
treatment of the condition. Request Free Sample
Report https//www.imarcgroup.com/diabetes-drugs-
diagnostics-market/requestsample
4
Report Description and Highlights
Report Description
Global Diabetes Drugs and Diagnostics Market
Trends The market is primarily driven by the
increasing incidences of diabetes across the
globe. This can be attributed to the sedentary
lifestyle led by the majority of the population
and its unhealthy food consumption patterns. The
growing awareness regarding the adverse effects
of the chronic disorder has impelled the demand
for early diagnostics among the masses. This,
along with the easy accessibility to innovative
diabetes diagnostic solutions, is creating a
positive outlook for the market. Moreover, a
considerable increase in the geriatric population
is also expected to provide an impetus to the
market growth as the elderly are always more
susceptible to such chronic ailments. The market
is further driven by the growing popularity of
self-monitoring devices among patients. These
portable and easy-to-use devices assist users in
monitoring their blood sugar levels in a
hassle-free manner, without the help of
healthcare professionals. Additionally, the
advent of several web- and software-based blood
glucose tracking applications and data management
platforms is also providing a thrust to the
market growth. Furthermore, the launch of
innovative analytical technologies and the
continual development of low-cost and
non-invasive delivery systems for insulin are
acting as major growth-inducing factors. This is
supported by the growing preference for wearable
devices and digital diabetes management platforms
among the patients. Some of the other factors
contributing to the market growth include the
rising number of diabetes drugs under clinical
trials and increasing investments in the
healthcare infrastructure. Looking forward, the
market value is projected to reach a strong
growth during the forecast period (2021-2026).

5
Report Description and Highlights
Report Description

• Market Summary
• Breakup by Segment
• Oral Antidiabetics
•  
• Breakup by Class
• Biguanides
• Alpha-Glucosidase Inhibitors
• Sodium-Glucose Cotransport -2 Inhibitors (SGLT-2
  Inhibitors)
• Dipeptidyl Peptidase-4 Inhibitors (DPP-4
  Inhibitors)
• Sulfonylureas
• Dopamine -D2 Receptor Agonist
• Others
• Breakup by insulin Class
• Long Acting Insulin
• Fast Acting Insulin
• Short Acting
• Others

6
Report Description and Highlights
Report Description

• Breakup by Product Type
• Blood Glucose Meters
• Blood Glucose Strips
• Lancets
• Breakup by End-User
• Hospitals and Clinics
• Home Healthcare
• Ambulatory Care Centers
• Others
• Breakup by Region
• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India

7
Report Description and Highlights
Report Description

• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Argentina
• Columbia
• Chile
• Peru
• Others

8
Report Description and Highlights
Report Description

• Middle East and Africa Turkey
• Saudi Arabia
• Iran
• United Arab Emirates
• Others
• Note We are updating our reports, If you want
  latest primary and secondary data (2021-2026)
  with Cost Module, Business Strategy, Distribution
  Channel, etc. Click request free sample report.
• Competitive Landscape
• The report has also analysed the competitive
  landscape of the market along with the profiles
  of the key players.
• View Full Report with TOC List of Figure
  https//www.imarcgroup.com/diabetes-drugs-diagnost
  ics-market

9
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
10
Partial List of Clients
We are the trusted business partners to the
world's leading corporates, governments, and
institutions
A partial List of our Clients
11
Report Description and Highlights
Report Description

2019 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
12

Contact Us